deaths (OS)

mNSCLC - L1 - PDL1 positive metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - PDL1 positive

versus Standard of Care (SoC)
nivolumab alone vs. Standard of Care (SoC) 2 1.07 [0.86; 1.33], 1 RCT, I2=0%
inconclusive result